Skip to main
GL

GL Stock Forecast & Price Target

GL Analyst Ratings

Based on 9 analyst ratings
Buy
Strong Buy 22%
Buy 56%
Hold 22%
Sell 0%
Strong Sell 0%

Bulls say

Globe Life Inc. is poised for solid growth, with life premium growth projected at 4.0%-4.5% and health premiums expected to increase significantly by 14%-16% in the upcoming year, driven by enhanced marketing efforts and lead generation. Notably, a strong performance in mortality experience contributed to a substantial remeasurement gain of $150 million in the third quarter, reflecting favorable conditions within both life and health sectors. Additionally, management's upward revision of the 2025 EPS estimate to $14.50 indicates confidence in sustained profitability and aligns well with the company's long-term growth strategy.

Bears say

Globe Life Inc. projects operating earnings per share to grow only 3% at the midpoint by 2026, a significant reduction driven by updated assumptions and a substantial drop in expected life remeasurement gains, declining from $192 million to a range of $50-$100 million. The company is also facing several risks, including potential fines or reputational damage from an ongoing EEOC review, increased margin pressure due to rising health utilization, and challenges in recruiting a productive sales force. Furthermore, the anticipated underwriting margins for the Life segment are expected to be modest, while the Health segment's margins are predicted to be adversely affected by a shift towards lower-profit Medicare Supplement products.

GL has been analyzed by 9 analysts, with a consensus rating of Buy. 22% of analysts recommend a Strong Buy, 56% recommend Buy, 22% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Globe Life Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Globe Life Inc (GL) Forecast

Analysts have given GL a Buy based on their latest research and market trends.

According to 9 analysts, GL has a Buy consensus rating as of Mar 17, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $169.22, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $169.22, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Globe Life Inc (GL)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.